AP
MDCO

AHL Partners’s Medicines Co MDCO Stock Holding History

AHL Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-42,584
Closed -$1.22M – 851
2015
Q2 		$1.22M Sell
42,584
-127,900
-75% -$3.56M 0.05% 515
2015
Q1 		$4.78M Buy
170,484
+85,252
+100% +$2.39M 0.19% 209
2014
Q4 		$2.36M Buy
+85,232
New +$2.11M 0.12% 384

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AHL Partners's MDCO Position: Q3 2015 in Review

AHL Partners sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 42,584 shares — an estimated $1.22M sold.

AHL Partners first reported a position in MDCO in Q4 2014 and held it in 3 quarters. The position peaked at $4.78M in Q1 2015. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

  • AHL Partners reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
  • AHL Partners sold 42,584 Medicines Co shares in Q3 2015, an estimated $1.22M.
  • AHL Partners first reported a position in Medicines Co in Q4 2014 and held it in 3 quarters.
  • AHL Partners's Medicines Co position peaked at $4.78M in Q1 2015.
  • 183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on AHL Partners's 13F filing for Q3 2015, filed 16 Nov 2015.